fluoxetine has been researched along with Heroin Abuse in 10 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients of the group 1 received naltrexone (N) in dosage 50 mg/day and fluoxetine (F) in dosage 20 mg/day during 6 months." | 2.75 | [Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial]. ( Bespalov, AIu; Burakov, AM; Didenko, TIu; Egorova, VIu; Grineneko, AIa; Ivanova, EB; Krupitskiĭ, EM; Masalov, DV; Neznanov, NG; O'Brien, C; Romanova, TN; Tsoĭ-Podosenin, MV; Verbitskaia, EV; Woody, D; Zvartau, EE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lutz, PE | 2 |
| Ayranci, G | 2 |
| Chu-Sin-Chung, P | 1 |
| Matifas, A | 1 |
| Koebel, P | 1 |
| Filliol, D | 2 |
| Befort, K | 2 |
| Ouagazzal, AM | 1 |
| Kieffer, BL | 2 |
| Lalanne, L | 1 |
| Gavériaux-Ruff, C | 1 |
| Krupitskiĭ, EM | 1 |
| Zvartau, EE | 2 |
| Tsoĭ-Podosenin, MV | 1 |
| Masalov, DV | 2 |
| Burakov, AM | 2 |
| Egorova, VIu | 1 |
| Didenko, TIu | 1 |
| Romanova, TN | 2 |
| Ivanova, EB | 2 |
| Bespalov, AIu | 1 |
| Verbitskaia, EV | 1 |
| Neznanov, NG | 2 |
| Grineneko, AIa | 1 |
| O'Brien, C | 1 |
| Woody, D | 1 |
| Krupitsky, EM | 1 |
| Tsoy, MV | 1 |
| Egorova, VY | 1 |
| Didenko, TY | 1 |
| Bespalov, AY | 1 |
| Verbitskaya, EV | 1 |
| Grinenko, AY | 1 |
| O'Brien, CP | 1 |
| Woody, GE | 1 |
| Balon, R | 1 |
| Gerra, G | 1 |
| Fertonani, G | 1 |
| Zaimovic, A | 1 |
| Rota-Graziosi, I | 1 |
| Avanzini, P | 1 |
| Caccavari, R | 1 |
| Delsignore, R | 1 |
| Lucchini, A | 1 |
| Landabaso, MA | 1 |
| Iraurgi, I | 1 |
| Jiménez-Lerma, JM | 1 |
| Sanz, J | 1 |
| Fernádez de Corres, B | 1 |
| Araluce, K | 1 |
| Calle, R | 1 |
| Gutiérrez-Fraile, M | 1 |
| Maremmani, I | 1 |
| Castrogiovanni, P | 1 |
| Daini, L | 1 |
| Zolesi, O | 1 |
| Batki, SL | 1 |
| Manfredi, LB | 1 |
| Sorensen, JL | 1 |
| Jacob, P | 1 |
| Dumontet, R | 1 |
| Jones, RT | 1 |
| Pollack, MH | 1 |
| Rosenbaum, JF | 1 |
4 trials available for fluoxetine and Heroin Abuse
| Article | Year |
|---|---|
[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].
Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin Depend | 2010 |
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Dru | 2006 |
Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment.
Topics: Adult; Aggression; Antidepressive Agents, Second-Generation; Fenfluramine; Fluoxetine; Heroin Depend | 1995 |
A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Heroin Dependence; Humans; Male; Naltrexone; N | 1998 |
6 other studies available for fluoxetine and Heroin Abuse
| Article | Year |
|---|---|
Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Disease Models, Animal; Dorsal Raphe | 2014 |
Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease Models, Animal; Fluoxet | 2017 |
Fluoxetine for cocaine dependence in methadone maintenance.
Topics: Alcoholism; Cocaine; Dopamine Uptake Inhibitors; Drug Synergism; Fluoxetine; Heroin Dependence; Huma | 1994 |
Use of fluoxetine in heroin addiction.
Topics: Adult; Female; Fluoxetine; Follow-Up Studies; Heroin Dependence; Humans; Male; Patient Compliance | 1992 |
Fluoxetine for cocaine abuse in methadone patients: preliminary findings.
Topics: Adult; Cocaine; Female; Fluoxetine; Heroin Dependence; Humans; Male; Methadone; Substance-Related Di | 1990 |
Fluoxetine treatment of cocaine abuse in heroin addicts.
Topics: Adult; Cocaine; Female; Fluoxetine; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; S | 1991 |